Navigation thread
Navigation thread
Atopic Dermatitis
Make a donation
Make a donation
Joint project with . This link opens in a new tab.

Research into Atopic Dermatitis

Reading time: 1 min

Some new therapeutic targets are currently undergoing clinical trials or premarketing studies, these include interleukin inhibitors (interleukins are proteins related to immunity and inflammation processes) and Janus kinase inhibitors, also known as JAK inhibitors, which act by blocking the enzyme that leads to the growth of scar tissue. 

Read more Treatment at Hospital Clínic
Joint project with . This link opens in a new tab.

What is an allergy?

Consulta toda la información relacionada con Allergy

Read more

Substantiated information by:

Paula Ribó Gonzalez
Sara Gómez Armayones

Published: 15 May 2020
Updated: 15 May 2020

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.

Atopic Dermatitis related news